Revance Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RVNC and other ETFs, options, and stocks.

About RVNC

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. 

CEO
Mark J. Foley
CEOMark J. Foley
Employees
597
Employees597
Headquarters
Nashville, Tennessee
HeadquartersNashville, Tennessee
Founded
1999
Founded1999
Employees
597
Employees597

RVNC Key Statistics

Market cap
381.95M
Market cap381.95M
Price-Earnings ratio
-0.97
Price-Earnings ratio-0.97
Dividend yield
—
Dividend yield—
Average volume
1.80M
Average volume1.80M
High today
$3.81
High today$3.81
Low today
$3.62
Low today$3.62
Open price
$3.64
Open price$3.64
Volume
1.59M
Volume1.59M
52 Week high
$37.98
52 Week high$37.98
52 Week low
$3.61
52 Week low$3.61

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.